Loading...

Loading...

AstraZeneca, Ionis Aim for New Drug for Rare Disease
By Antonio Gozain - Tue, 06/21/2022 - 10:32
Amyloid transthyretin polyneuropathy is a rare and fatal disease that can affect up to 40,000 people worldwide, said AstraZeneca’s Mene Pangalos.